Table 2.
Univariate analysis for the primary outcome and thromboembolic events.
| Primary Outcome | Thromboembolic event | |||
|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | |
| Age | 1.02 (0.98–1.05) | 0.326 | 0.99 (0.96–1.04) | 0.935 |
| Male sex | 0.87 (0.42–1.80) | 0.699 | 0.52 (0.21–1.30) | 0.164 |
| Body mass index | 1.03 (0.91–1.15) | 0.686 | 1.09 (0.94–1.25) | 0.257 |
| Hypertension | 1.29 (0.61–2.74) | 0.505 | 1.05 (0.44–2.48) | 0.921 |
| Diabetes mellitus | 1.26 (0.48–3.30) | 0.643 | 0.66 (0.15–2.82) | 0.572 |
| Chronic kidney disease | 1.42 (0.43–4.70) | 0.571 | 1.35 (0.31–5.86) | 0.685 |
| Previous stroke | 1.65 (0.63–4.37) | 0.311 | 0.83 (0.19–3.58) | 0.798 |
| Coronary artery disease | 3.01 (1.37–6.57) | 0.006 | 1.19 (0.39–3.67) | 0.759 |
| CHA 2 DS 2 -VASc score | 1.28 (1.03–1.57) | 0.023 | 1.09 (0.84–1.41) | 0.507 |
| Rheumatic heart disease | 0.74 (0.28–1.93) | 0.532 | 0.84 (0.28–2.49) | 0.750 |
| Bioprosthetic valve | 0.99 (0.23–4.20) | 0.988 | 1.56 (0.36–6.82) | 0.554 |
| Mechanical valve | 0.92 (0.39–2.16) | 0.850 | 1.14 (0.44–2.94) | 0.792 |
| Mitral valve repair | 1.08 (0.49–2.37) | 0.854 | 0.78 (0.32–1.88) | 0.579 |
| Aortic valve replacement | 2.33 (0.99–5.45) | 0.052 | 2.92 (1.13–7.54) | 0.027 |
| CABG | 2.92 (1.00–8.53) | 0.049 | 0.00 (0–Inf) | 0.997 |
| Tricuspid surgery | 0.98 (0.45–2.13) | 0.958 | 0.87 (0.36–2.14) | 0.768 |
| Maze | 0.31 (0.13–0.77) | 0.011 | 0.20 (0.06–0.69) | 0.011 |
| LV end-systolic diameter | 1.03 (0.98–1.08) | 0.208 | 1.02 (0.96–1.08) | 0.585 |
| LV end-diastolic diameter | 1.02 (0.97–1.06) | 0.519 | 1.01 (0.96–1.06) | 0.705 |
| LV ejection fraction | 0.97 (0.94–1.00) | 0.061 | 0.98 (0.94–1.02) | 0.291 |
| LA volume index | 1.00 (0.99–1.01) | 0.603 | 1.00 (0.99–1.01) | 0.470 |
| LAAO | 0.22(0.08–0.63) | 0.005 | 0.14 (0.03–0.62) | 0.009 |
| LAA shape, cauliflower | 2.17 (1.00–4.67) | 0.049 | 3.13 (1.30–7.52) | 0.011 |
| LA volume | 1.00 (0.99–1.00) | 0.752 | 1.00 (0.99–1.00) | 0.378 |
| LAA volume | 1.01 (0.99–1.03) | 0.327 | 1.01 (0.99–1.03) | 0.139 |
| LAA os diameter | 1.00 (0.95–1.05) | 0.970 | 1.02 (0.96–1.07) | 0.577 |
| LAA os perimeter | 1.00 (0.99–1.02) | 0.972 | 1.01 (0.99–1.02) | 0.590 |
| LAA os area | 1.01 (0.94–1.10) | 0.756 | 1.03 (0.94–1.13) | 0.514 |
| Adequate anticoagulation | 0.78 (0.37–1.66) | 0.520 | 1.16 (0.45–2.99) | 0.761 |
| Postoperative AF | 1.97 (0.87–4.45) | 0.103 | 2.41 (0.88–6.59) | 0.086 |
CABG, coronary artery bypass grafting; LV, left ventricular; LA, left atrial; LAA, left atrial appendage; AF, atrial fibrillation; LA, left atrial; LAA, left atrial appendage; LV, left ventricular